FHTX Competitors & Alternatives
Compare Foghorn Therapeutics Inc with similar stocks in the same industry
Biotechnology
FHTX
Main Stock$2.09
Tradestie Score
35
Market Cap
$278.69M
P/E Ratio
21.1
Revenue Growth
9.2%
Analyst Upside
+99.4%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.00
|
$154.27M | - | 48 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$2.89
|
$153.02M | - | 40 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.25
|
$133.50M | - | 29 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.88
|
$117.07M | - | 30 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.05
|
$114.01M | - | 48 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$31.15
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.78
|
$97.42M | - | 33 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$3.78
|
$85.47M | - | 44 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.22
|
$84.52M | - | 41 | Compare |
More FHTX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry